Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1780447

Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma : a southwest oncology group trial

Author
MARGOLIN, K. A1 ; LIU, P. Y2 ; WEISS, G. R9 ; SONDAK, V. K10 ; UNGER, J. M2 ; FLETCHER, W. S3 ; FLAHERTY, L. E4 ; URBA, W. J5 ; HERSH, E. M6 ; HUTCHINS, L. E7 ; SOSMAN, J. A8 ; SMITH, J. W5
[1] Department of Medical Oncology, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010-3000, United States
[2] Southwest Oncology Group Statistical Center, Seattle, WA, United States
[3] Oregon Health Sciences University, Portland, OR, United States
[4] Wayne State University Medical Center, Detroit, MI, United States
[5] Columbia River CCOP, Portland, OR, United States
[6] University of Arkansas for Medical Science, Little Rock, AR, United States
[7] University of Arizona Cancer Center, Tucson, AZ, United States
[8] University of Illinois at Chicago, IL, United States
[9] University of Texas Health Science Center at San Antonio, TX, United States
[10] University of Michigan Medical Center, Ann Arbor, MI, United States
Source

Journal of cancer research and clinical oncology. 1999, Vol 125, Num 5, pp 292-296 ; ref : 23 ref

CODEN
JCROD7
ISSN
0171-5216
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
Springer, Berlin
Publication country
Germany
Document type
Article
Language
English
Keyword (fr)
Anticancéreux Cisplatine Composé non stéroïde Dacarbazine Efficacité traitement Essai clinique phase II Homme Immunochimiothérapie Interféron alpha Mélanome malin Platine II Complexe Stade avancé Tamoxifène Tolérance Toxicité Traitement associé Traitement induction Voie intraveineuse Voie orale Voie souscutanée Cytokine Tumeur maligne
Keyword (en)
Antineoplastic agent Cisplatin Non steroid compound Dacarbazine Treatment efficiency Phase II trial Human Immunochemotherapy Alpha interferon Malignant melanoma Platinum II Complexes Advanced stage Tamoxifene Tolerance Toxicity Combined treatment Induction treatment Intravenous administration Oral administration Subcutaneous administration Cytokine Malignant tumor
Keyword (es)
Anticanceroso Cisplatino Compuesto no esteroide Dacarbazina Eficacia tratamiento Ensayo clínico fase II Hombre Inmunoquimioterapia Interferón alfa Melanoma maligno Platino II Complejo Estadio avanzado Tamoxifeno Tolerancia Toxicidad Tratamiento asociado Tratamiento inductivo Vía intravenosa Vía oral Vía subcutánea Citoquina Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R04 Combined treatments (chemotherapy of immunotherapy associated with an other treatment)

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
1780447

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web